United States Non-Vascular Stents Market Outlook to 2023

GlobalData
61 Pages - GLDATA62115
$4,995.00

Summary

GlobalData’s new report, United States Non-Vascular Stents Market Outlook to 2023, provides key market data on the United States Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Pancreatic and Biliary Stents, Enteral Stents, Airway Stents and Urinary Tract Stents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Non-Vascular Stents market segments - Pancreatic and Biliary Stents, Enteral Stents, Airway Stents and Urinary Tract Stents.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Non-Vascular Stents market.
- Key players covered include Boston Scientific Corp, C. R. Bard Inc, W. L. Gore & Associates Inc and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Boston Scientific Corp
C. R. Bard Inc
Cook Group Inc
W. L. Gore & Associates Inc
Taewoong Medical Co.,Ltd.
EndoChoice Inc
Allium Medical Solutions Ltd

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Non-Vascular Stents Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Non-Vascular Stents Market, United States 8
3.1 Non-Vascular Stents Market, United States, Revenue ($m), 2009-2016 8
3.2 Non-Vascular Stents Market, United States, Revenue ($m), 2016-2023 10
3.2.1 Airway Stents Market, United States, Revenue ($m), by Segment, 2009-2016 12
3.2.2 Enteral Stents Market, United States, Revenue ($m), by Segment, 2009-2016 14
3.2.3 Pancreatic and Biliary Stents Market, United States, Revenue ($m), by Segment, 2009-2016 16
3.2.4 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2009-2016 18
3.2.5 Airway Stents Market, United States, Revenue ($m), by Segment, 2016-2023 20
3.2.6 Enteral Stents Market, United States, Revenue ($m), by Segment, 2016-2023 22
3.2.7 Pancreatic and Biliary Stents Market, United States, Revenue ($m), by Segment, 2016-2023 24
3.2.8 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2016-2023 26
3.3 Non-Vascular Stents Market, United States, Volume (Units), 2009-2016 28
3.4 Non-Vascular Stents Market, United States, Volume (Units), 2016-2023 30
3.4.1 Airway Stents Market, United States, Volume (Units), by Segment, 2009-2016 32
3.4.2 Enteral Stents Market, United States, Volume (Units), by Segment, 2009-2016 34
3.4.3 Pancreatic and Biliary Stents Market, United States, Volume (Units), by Segment, 2009-2016 36
3.4.4 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2009-2016 38
3.4.5 Airway Stents Market, United States, Volume (Units), by Segment, 2016-2023 40
3.4.6 Enteral Stents Market, United States, Volume (Units), by Segment, 2016-2023 42
3.4.7 Pancreatic and Biliary Stents Market, United States, Volume (Units), by Segment, 2016-2023 44
3.4.8 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2016-2023 46
3.5 Non-Vascular Stents Market, United States, Average Price ($), 2009-2023 48
3.6 Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), 2016 50
3.7 Non-Vascular Stents Market, United States, Company Share by Revenue ($m), 2016 51
4 Overview of Key Companies in United States, Non-Vascular Stents Market 53
4.1 Boston Scientific Corp 53
4.1.1 Company Overview 53
4.2 C. R. Bard Inc 53
4.2.1 Company Overview 53
4.3 Cook Group Inc 53
4.3.1 Company Overview 53
4.4 W. L. Gore & Associates Inc 53
4.4.1 Company Overview 53
4.5 Taewoong Medical Co.,Ltd. 54
4.5.1 Company Overview 54
4.6 EndoChoice Inc 54
4.6.1 Company Overview 54
4.7 Allium Medical Solutions Ltd 54
4.7.1 Company Overview 54
5 Appendix 55
5.1 Research Methodology 56
5.1.1 Coverage 56
5.1.2 Secondary Research 56
5.1.3 Primary Research 57
5.1.4 Market Modeling and Forecasting 58
5.1.5 Company Share Analysis 59
5.1.6 Distribution Share Analysis 60
5.1.7 Benchmarking 60
5.2 GlobalData Consulting 60
5.3 Contact Us 61
5.4 Disclaimer 61

1.1 List of Tables
Table 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
Table 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
Table 3: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
Table 4: Enteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
Table 5: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 6: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 19
Table 7: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 21
Table 8: Enteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 23
Table 9: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 25
Table 10: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 27
Table 11: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2009-2016 29
Table 12: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2016-2023 31
Table 13: Airway Stents Market, United States, Volume (Units), Historic, 2009-2016 33
Table 14: Enteral Stents Market, United States, Volume (Units), Historic, 2009-2016 35
Table 15: Pancreatic and Biliary Stents Market, United States, Volume (Units), Historic, 2009-2016 37
Table 16: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2009-2016 39
Table 17: Airway Stents Market, United States, Volume (Units), Forecast, 2016-2023 41
Table 18: Enteral Stents Market, United States, Volume (Units), Forecast, 2016-2023 43
Table 19: Pancreatic and Biliary Stents Market, United States, Volume (Units), Forecast, 2016-2023 45
Table 20: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2016-2023 47
Table 21: Non-Vascular Stents Market, United States, Average Price ($) Historic, 2009-2016 48
Table 22: Non-Vascular Stents Market, United States, Average Price ($), Forecast, 2016-2023 49
Table 23: Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 50
Table 24: Non-Vascular Stents Market, United States, Company Share by Revenue ($m), USD Constant, 2016 52
Table 25: Total Number of Primary Research Participants, General Surgery Market, by Country 58

1.2 List of Figures
Figure 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8
Figure 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10
Figure 3: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 12
Figure 4: Enteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
Figure 5: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 18
Figure 7: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Figure 8: Enteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 22
Figure 9: Pancreatic and Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
Figure 10: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 26
Figure 11: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2009-2016 28
Figure 12: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2016-2023 30
Figure 13: Airway Stents Market, United States, Volume (Units), Historic, 2009-2016 32
Figure 14: Enteral Stents Market, United States, Volume (Units), Historic, 2009-2016 34
Figure 15: Pancreatic and Biliary Stents Market, United States, Volume (Units), Historic, 2009-2016 36
Figure 16: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2009-2016 38
Figure 17: Airway Stents Market, United States, Volume (Units), Forecast, 2016-2023 40
Figure 18: Enteral Stents Market, United States, Volume (Units), Forecast, 2016-2023 42
Figure 19: Pancreatic and Biliary Stents Market, United States, Volume (Units), Forecast, 2016-2023 44
Figure 20: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2016-2023 46
Figure 21: Non-Vascular Stents Market, United States, Company Share (%) 2016 51

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838